IP Library Granted Patent US 8,828,961
Granted Patent B2
US 8,828,961 · App. 13/277,066 · Granted Sep 9, 2014

Methods and compositions to protect aquatic invertebrates from disease

Inventors: John Dustin Loy (Ames, IA); Lyric Colleen Bartholomay (Ames, IA); Delbert Linn Harris (Ames, IA); Ed Scura (Potomac, MD); Kurt Iver Kamrud (Apex, NC)
Assignee: Harrisvaccines
A61K39/145A61K39/135C12N2710/18034C12N2760/16134C12N2760/16122C07K14/005C12N2320/32C12N2770/10022C12N2770/32134C12N2720/00034C12N2770/32122C12N2720/00022C12N15/111C12N2310/14A61K39/12C12N2310/111C12N15/86C12N2770/36143C12N2710/18022C12N15/1131
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,961
App. No.
13/277,066
Granted
Sep 9, 2014
Kind
B2
Abstract

Compositions and methods of protecting aquatic invertebrates from disease is shown. In one embodiment, dsRNA or antisense RNA to a nucleic acid molecule of the disease-causing microorganism is prepared and delivered to the animal. In another embodiment, a nucleic acid molecule of the disease-causing microorganism is delivered to the animal. In another embodiment, the RNA or nucleic acid molecule is delivered to the animal by replicon particle. In a further embodiment, the protective molecule is delivered to the digestive tract of the animal. Protection from disease is obtained.

Claims (31)

1. A method of protecting shrimp from disease, the method comprising,

a) identifying a target nucleic acid molecule of a microorganism causing said disease;

b) preparing a composition comprising a protective molecule selected from the group consisting of:

(i) a dsRNA molecule comprising at least one RNA molecule that is capable of hybridizing to said target nucleic acid molecule of said microorganism; and

(ii) an antisense RNA molecule comprising a sequence that is the full or partial complement of said target nucleic acid molecule of said microorganism,

wherein said composition does not comprise an expression cassette or vector comprising said protective molecule; and

c) orally administering said composition comprising said protective molecule to shrimp wherein said shrimp is protected from said disease.

2. The method of claim 1 , wherein said at least one RNA molecule comprising a sequence that corresponds to all or a portion of said target nucleic acid molecule is selected from the group consisting of an RNA molecule of at least 10 bp, at least 20 bp, at least 30 bp and at least 50 bp.

3. The method of claim 1 , wherein said dsRNA comprises at least one RNA molecule that is the full or partial complement of all or a portion of said target nucleic acid molecule.

4. The method of claim 3 , wherein said at least one RNA molecule comprising a sequence that corresponds to all or a portion of said target nucleic acid molecule and said at least one RNA molecule that is the full or partial complement of all or a portion of said target nucleic acid molecule is selected from the group consisting of an RNA molecule of at least 10 bp, at least 20 bp, at least 30 bp and at least 50 bp.

5. The method of claim 1 , wherein said disease comprises White Spot Syndrome Virus (WSSV).

6. The method of claim 1 , wherein said target nucleic acid molecule comprises a nucleic acid molecule encoding White Spot Syndrome Virus (WSSV) VP19 or a fragment thereof, wherein said nucleic acid molecule or fragment thereof produces a protective molecule that when administered to said shrimp, protects said shrimp from said WSSV.

7. The method of claim 6 , wherein said target nucleic acid molecule comprises SEQ ID NO: 30 or a fragment thereof.

8. The method of claim 1 , wherein said dsRNA is produced by a nucleic acid molecule comprising SEQ ID NO: 32, or the complement thereof, or a fragment of said nucleic acid molecule, wherein said dsRNA produces a protective response.

9. The method of claim 3 , wherein said sequence that corresponds to all or a portion of said target nucleic acid molecule is selected from the group consisting of SEQ ID NO: 35, SEQ ID NO: 37, SEQ ID NO: 39, SEQ ID NO: 41, SEQ ID NO: 52, SEQ ID NO: 57, and SEQ ID NO: 62 and a fragment thereof, and said RNA that is the full or partial complement of all or a portion of said target nucleic acid molecule is selected from the group consisting of SEQ ID NO: 36, SEQ ID NO: 38, SEQ ID NO: 40, SEQ ID NO: 42, SEQ ID NO: 53, SEQ ID NO: 58, and SEQ ID NO: 63 and a fragment thereof.

10. The method of claim 3 , wherein said sequence that corresponds to all or a portion of said target nucleic acid comprises SEQ ID NO: 49 or fragments thereof, and said RNA that is the full or partial complement of all or a portion of said target nucleic acid molecule comprises SEQ ID NO: 50 or fragments thereof.

11. The method of claim 1 , wherein protective molecule is administered such that said molecule is delivered to the digestive tract of said shrimp.

12. The method of claim 1 , wherein said animal is protected from said disease for a period of time selected from the group consisting of at least 20 days, at least 25 days, at least 30 days, at least 40 days and at least 60 days following administration of said protective molecule.

13. A method of protecting shrimp from disease, the method comprising,

a) identifying a target nucleic acid molecule of a microorganism causing said disease;

b) preparing a composition comprising a protective molecule comprising

a dsRNA molecule comprising at least one RNA molecule that is capable of hybridizing to said target nucleic acid molecule of said microorganism,

wherein said composition does not comprise an expression cassette or vector comprising said protective molecule; and

c) orally administering said composition comprising said protective molecule to said shrimp, wherein said shrimp is protected from said disease.

14. A method of protecting shrimp from disease, the method comprising,

a) identifying a target nucleic acid molecule of a microorganism causing said disease;

b) preparing a composition comprising a protective comprising

an antisense RNA molecule comprising a sequence that is the full or partial complement of said target nucleic acid molecule of said microorganism,

wherein said composition does not comprise an expression cassette or vector comprising said protective molecule; and

c) orally administering said composition comprising said protective molecule to said shrimp, wherein said shrimp is protected from said disease.

15. The method of claim 14 wherein said protective molecule comprises SEQ ID NO: 31 or a fragment thereof, wherein said, protective molecule when administered to said shrimp protects said shrimp from said disease.

Assignments (2)
CHANGE OF NAME Recorded Apr 8, 2022
From: HARRISEVACCINES INC.
To: HARRISVACCINES LLC
Reel/Frame 059657/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: BARTHOLOMAY, LYRIC COLLEEN; ERDMAN, MATTHEW; HARRIS, DELBERT LINN; KAMRUD, KURT IVER; SCURA, ED; SMITH, JONATHAN; LOY, JOHN DUSTIN
To: HARRISVACCINES, INC.
Reel/Frame 035317/0800 →
Continuity (7)
Provisional Application 61407297 · Oct 27, 2010
Provisional Application 61418433 · Dec 1, 2010
Provisional Application 61449940 · Mar 7, 2011
Provisional Application 61484255 · May 10, 2011
Provisional Application 61508172 · Jul 15, 2011
Provisional Application 61525332 · Aug 19, 2011
Related Publication 20120108649A1 · May 3, 2012